Zheng X - Search Results

1

Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy.

Zheng X, Gao Y, Yu C, Fan G, Li P, Zhang M, Yu J, Xu M. Zheng X, et al. Sci Rep. 2021 Sep 30;11(1):19432. doi: 10.1038/s41598-021-98966-x. Sci Rep. 2021. PMID: 34593914 Free PMC article.

2

The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.

Xu L, Zhang M, Zheng X, Yi P, Lan C, Xu M. Xu L, et al. Among authors: zheng x. J Cancer Res Clin Oncol. 2017 Jan;143(1):17-27. doi: 10.1007/s00432-016-2256-7. Epub 2016 Sep 10. J Cancer Res Clin Oncol. 2017. PMID: 27614453

3

miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.

Zheng XB, Chen XB, Xu LL, Zhang M, Feng L, Yi PS, Tang JW, Xu MQ. Zheng XB, et al. Cancer Sci. 2017 Mar;108(3):338-346. doi: 10.1111/cas.13167. Cancer Sci. 2017. PMID: 28100026 Free PMC article.

4

MicroRNA-203 promotes liver regeneration after partial hepatectomy in cirrhotic rats.

Chen XB, Zheng XB, Cai ZX, Lin XJ, Xu MQ. Chen XB, et al. J Surg Res. 2017 May 1;211:53-63. doi: 10.1016/j.jss.2016.11.043. Epub 2016 Nov 28. J Surg Res. 2017. PMID: 28501131

5

Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.

Xu LL, Zhang M, Yi PS, Zheng XB, Feng L, Lan C, Tang JW, Ren SS, Xu MQ. Xu LL, et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):974-980. doi: 10.1007/s11596-017-1836-3. Epub 2017 Dec 21. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29270762

6

Using the recurrence risk score by Joensuu to assess patients with gastrointestinal stromal tumor treated with adjuvant imatinib: A retrospective cohort study.

Tang J, Zhao R, Zheng X, Xu L, Wang Y, Feng L, Ren S, Wang P, Zhang M, Xu M. Tang J, et al. Among authors: zheng x. Medicine (Baltimore). 2018 Jul;97(29):e11400. doi: 10.1097/MD.0000000000011400. Medicine (Baltimore). 2018. PMID: 30024511 Free PMC article.

7

The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.

Xu L, Zhang Y, Tang J, Wang P, Li L, Yan X, Zheng X, Ren S, Zhang M, Xu M. Xu L, et al. Among authors: zheng x. Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):867-881. doi: 10.1158/1055-9965.EPI-18-0570. Epub 2019 Jan 2. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30602498

8

CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.

Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, Li L, Ren S, Zhang M, Xu M. Xu L, et al. Among authors: zheng x. J Exp Clin Cancer Res. 2019 Feb 22;38(1):98. doi: 10.1186/s13046-019-1041-2. J Exp Clin Cancer Res. 2019. PMID: 30795787 Free PMC article.

9

SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.

Xu L, Wang P, Feng X, Tang J, Li L, Zheng X, Zhang J, Hu Y, Lan T, Yuan K, Zhang Y, Ren S, Hao X, Zhang M, Xu M. Xu L, et al. Among authors: zheng x. Clin Sci (Lond). 2019 Oct 30;133(20):2085-2105. doi: 10.1042/CS20190666. Clin Sci (Lond). 2019. PMID: 31654063

10

Correlation between the expressions of circular RNAs in peripheral venous blood and clinicopathological features in hepatocellular carcinoma.

Wang P, Xu LL, Zheng XB, Hu YT, Zhang JF, Ren SS, Hao XY, Li L, Zhang M, Xu MQ. Wang P, et al. Ann Transl Med. 2020 Mar;8(6):338. doi: 10.21037/atm.2020.02.134. Ann Transl Med. 2020. PMID: 32355782 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,153 results

Search Page

Filters